JPWO2020113084A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020113084A5
JPWO2020113084A5 JP2021529785A JP2021529785A JPWO2020113084A5 JP WO2020113084 A5 JPWO2020113084 A5 JP WO2020113084A5 JP 2021529785 A JP2021529785 A JP 2021529785A JP 2021529785 A JP2021529785 A JP 2021529785A JP WO2020113084 A5 JPWO2020113084 A5 JP WO2020113084A5
Authority
JP
Japan
Prior art keywords
seq
antigen
binding fragment
monoclonal antibody
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021529785A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513437A (ja
JP2022513437A5 (https=
JP7478149B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063729 external-priority patent/WO2020113084A1/en
Publication of JP2022513437A publication Critical patent/JP2022513437A/ja
Publication of JPWO2020113084A5 publication Critical patent/JPWO2020113084A5/ja
Publication of JP2022513437A5 publication Critical patent/JP2022513437A5/ja
Application granted granted Critical
Publication of JP7478149B2 publication Critical patent/JP7478149B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021529785A 2018-11-28 2019-11-27 治療用第ｘｉｉ因子抗体 Active JP7478149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862772235P 2018-11-28 2018-11-28
US62/772,235 2018-11-28
PCT/US2019/063729 WO2020113084A1 (en) 2018-11-28 2019-11-27 Therapeutic factor xii antibody

Publications (4)

Publication Number Publication Date
JP2022513437A JP2022513437A (ja) 2022-02-08
JPWO2020113084A5 true JPWO2020113084A5 (https=) 2022-09-29
JP2022513437A5 JP2022513437A5 (https=) 2022-09-29
JP7478149B2 JP7478149B2 (ja) 2024-05-02

Family

ID=69024611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021529785A Active JP7478149B2 (ja) 2018-11-28 2019-11-27 治療用第ｘｉｉ因子抗体

Country Status (5)

Country Link
US (1) US12134657B2 (https=)
EP (1) EP3886982A1 (https=)
JP (1) JP7478149B2 (https=)
CN (1) CN113423465B (https=)
WO (1) WO2020113084A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023531315A (ja) * 2020-07-03 2023-07-21 シーエスエル・イノベーション・プロプライエタリー・リミテッド 第ｘｉｉ因子抗原結合タンパク質の高濃度製剤
CN116265945B (zh) * 2022-01-05 2025-12-09 上海迈晋生物医药科技有限公司 抗凝血药物的生物学活性检测方法
EP4729546A1 (en) * 2023-06-16 2026-04-22 Jiangsu BioJeTay Biotechnology Co., Ltd. Antibody specifically recognizing factor xiia and use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4938948A (en) 1985-10-07 1990-07-03 Cetus Corporation Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
JPH049249A (ja) 1990-04-27 1992-01-14 Kusuda:Kk 塗型剤吹き付け機
WO2003013423A2 (en) 2001-08-05 2003-02-20 Gvg, Inc. Antithrombotic agent
CA2591786C (en) 2004-12-23 2013-07-16 Bernhard Nieswandt Prevention of thrombus formation and/or stabilization
ES3005912T3 (en) * 2011-07-22 2025-03-17 Csl Behring Gmbh Inhibitory anti-factor xii/xiia monoclonal antibodies and their uses
CN202179824U (zh) 2011-07-22 2012-04-04 北京美亚视景创恒科技有限公司 数字健身设备集群系统
WO2014089493A1 (en) 2012-12-07 2014-06-12 Vanderbilt University Antibodies against factor xii and uses thereof
BR112016029624A2 (pt) * 2014-06-18 2017-10-24 Csl Behring Gmbh terapia usando um inibidor do fator xii em um distúrbio neurotraumático

Similar Documents

Publication Publication Date Title
CN105037543B (zh) 治疗性dll4结合蛋白
WO2019024911A1 (zh) B7h3抗体-药物偶联物及其医药用途
JP2021530251A (ja) 新規な抗体ならびにそれを調製および使用するための方法
US20220041721A1 (en) Cd3 antigen binding fragment and application thereof
RU2671955C2 (ru) Лечение сосудистого заболевания и его осложнений
MX2010011955A (es) Inmunoglobulinas de dominio variable doble y usos de las mismas.
MX2010013236A (es) Inmunoglobulinas de dominio variable doble y usos de las mismas.
TW202126693A (zh) 標靶bcma的抗體、雙專一性抗體及其用途
CN117279950B (zh) 一种靶向il-18bp的抗体及其应用
WO2022199590A1 (zh) 一种靶向bcma的纳米抗体及其应用
JP2022513437A5 (https=)
CN112830969A (zh) 一种特异性结合人Claudin18.2的单克隆抗体及包含其的药物和试剂盒
JP2019510474A (ja) トロンビン抗体、その抗原結合フラグメント及び医薬用途
CN114591434A (zh) 抗Siglec15抗体及其制备方法和用途
CN113906053A (zh) 抗cea抗体及其应用
JP2026027248A (ja) 抗原結合分子およびその使用
JP2025524306A (ja) Ｉｔｇａ２を標的とする抗体及びそれを含む抗体薬物複合体
JPWO2020113084A5 (https=)
JPWO2022159984A5 (https=)
JP7457880B2 (ja) 新規なＮａｖ１．７モノクローナル抗体
CN110642950A (zh) 一种人源化t细胞活化的v域免疫抑制因子抗原结合片段
CN120187752A (zh) 人源化的l1cam抗体药物偶联物
KR20240155885A (ko) 항변이 calr 항체와 다른 약제를 조합하여 이루어진 의약
CN113597432B (zh) 抗EpCAM抗体及其应用
US8114969B2 (en) Immunotoxin derived from a recombinant human autoantibody and method of using thereof